首页 | 本学科首页   官方微博 | 高级检索  
     


Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices
Authors:Amrita D. Singh  Sapna Parmar  Khilna Patel  Shreya Shah  Tsiporah Shore  Usama Gergis  Sebastian Mayer  Adrienne Phillips  Jing-Mei Hsu  Ruben Niesvizky  Tomer M. Mark  Roger Pearse  Adriana Rossi  Koen van Besien
Abstract:
Administration of granulocyte colony-stimulating factor (G-CSF) after autologous peripheral blood stem cell transplantation (PBSCT) is generally recommended to reduce the duration of severe neutropenia; however, data regarding the optimal timing of G-CSFs post-transplantation are limited and conflicting. This retrospective study was performed at NewYork-Presbyterian/Weill Cornell Medical Center between November 5, 2013, and August 9, 2016, of adult inpatient autologous PBSCT recipients who received G-CSF empirically starting on day +5 (early) versus on those who received G-CSF on day +12 only if absolute neutrophil count (ANC) was <0.5?×?109/L (ANC-driven). G-CSF was dosed at 300?µg in patients weighing <75?kg and 480?µg in those weighing ≥75?kg. One hundred consecutive patients underwent autologous PBSCT using either the early (n?=?50) or ANC-driven (n?=?50) G-CSF regimen. Patient and transplantation characteristics were comparable in the 2 groups. In the ANC-driven group, 24% (n?=?12) received G-CSF on day +12 and 60% (n?=?30) started G-CSF earlier due to febrile neutropenia or at the physician's discretion, 6% (n?=?3) started after day +12 at the physician's discretion, and 10% (n?=?5) did not receive any G-CSF. The median start day of G-CSF therapy was day +10 in the ANC-driven group versus day +5 in the early group (P?P?=?.07). There were no significant between-group differences in time to platelet engraftment, 1-year relapse rate, or 1-year overall survival. The incidence of febrile neutropenia was 74% in the early group versus 90% in the ANC-driven group (P?=?.04); however, there was no significant between-group difference in the incidence of positive bacterial cultures or transfer to the intensive care unit. The duration of G-CSF administration until neutrophil engraftment was 6 days in the early group versus 3 days in the ANC-driven group (P?P?=?.28). Our data show that early initiation of G-CSF (on day +5) and ANC-driven initiation of G-CSF following autologous PBSCT were associated with a similar time to neutrophil engraftment, length of stay post-transplantation, and 1-year overall survival.
Keywords:Granulocyte colony-stimulating factor  Engraftment  Autologous  Stem cell transplant
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号